Results 21 to 30 of about 2,422 (183)

Functional recovery of a novel knockin mouse model of dysferlinopathy by readthrough of nonsense mutation

open access: yesMolecular Therapy: Methods & Clinical Development, 2021
Biallelic mutations in the dysferlin gene cause limb-girdle muscular dystrophy 2B or Miyoshi distal myopathy. We found that nonsense mutations are the most common mutation type among Korean patients with dysferlinopathy; more than half of the patients ...
Kyowon Seo   +4 more
doaj   +1 more source

Miyoshi myopathy and limb girdle muscular dystrophy R2 are the same disease [PDF]

open access: yesNeuromuscular Disorders, 2021
This study aims to determine clinically relevant phenotypic differences between the two most common phenotypic classifications in dysferlinopathy, limb girdle muscular dystrophy R2 (LGMDR2) and Miyoshi myopathy (MMD1). LGMDR2 and MMD1 are reported to involve different muscles, with LGMDR2 showing predominant limb girdle weakness and MMD1 showing ...
Moore, Ursula   +26 more
openaire   +12 more sources

EFFECT OF STRUCTURED EXERCISE REGIMEN ON QUALITY OF LIFE, BALANCE AND STRENGTH ON A PATIENT WITH MIYOSHI MYOPATHY – A CASE REPORT

open access: yesInternational Journal of Physiotherapy, 2020
Background: Dysferlinopathy is an autosomal recessive disease seen in adolescence or young adulthood. Miyoshi Myopathy is characterized by weakness and wasting of posterior compartment leg muscles rather than the anterior compartment and distal upper ...
Abhishek Taklekar   +2 more
doaj   +1 more source

Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle. [PDF]

open access: yesPLoS ONE, 2010
Dysferlin is a type II transmembrane protein implicated in surface membrane repair in muscle. Mutations in dysferlin lead to limb girdle muscular dystrophy 2B, Miyoshi Myopathy and distal anterior compartment myopathy.
Bilal A Azakir   +3 more
doaj   +1 more source

Lower Limb Radiology of Distal Myopathy due to the S60F Myotilin Mutation [PDF]

open access: yes, 2009
Distal myopathies are a clinically and genetically heterogenous group of disorders in which the distal limb musculature is selectively or disproportionately affected.
Birchall, Daniel   +8 more
core   +1 more source

Crystal structures of the human Dysferlin inner DysF domain [PDF]

open access: yes, 2014
Background: Mutations in dysferlin, the first protein linked with the cell membrane repair mechanism, causes a group of muscular dystrophies called dysferlinopathies.
Cole, Ambrose R.   +4 more
core   +1 more source

Combined sequence and copy number analysis improves diagnosis of limb girdle and other myopathies

open access: yesAnnals of Clinical and Translational Neurology, Volume 10, Issue 11, Page 2092-2104, November 2023., 2023
Abstract Objective Clinical and genetic heterogeneities make diagnosis of limb‐girdle muscular dystrophy (LGMD) and other overlapping disorders of muscle weakness complicated and expensive. We aimed to develop a comprehensive next generation sequence‐based multi‐gene panel (“The Lantern Focused Neuromuscular Panel”) to detect both sequence variants and
Babi R. R. Nallamilli   +8 more
wiley   +1 more source

Functional muscle hypertrophy by increased insulin-like growth factor 1 does not require dysferlin. [PDF]

open access: yes, 2019
IntroductionDysferlin loss-of-function mutations cause muscular dystrophy, accompanied by impaired membrane repair and muscle weakness. Growth promoting strategies including insulin-like growth factor 1 (IGF-1) could provide benefit but may cause ...
Barton, Elisabeth R   +9 more
core   +1 more source

Calf-Head Sign in Miyoshi Myopathy [PDF]

open access: yesArchives of Neurology, 2006
To observe whether patients with Miyoshi-type dysferlinopathy demonstrate any distinct appearance in the back of the shoulders and upper back in a specific posture.Case series.Neurology outpatient clinic of a north Indian tertiary care medical institute.Fifteen patients from 9 families (10 males and 5 females; age range, 16-42 years) who had Miyoshi ...
openaire   +2 more sources

Translational implications of targeting annexin A2: From membrane repair to muscular dystrophy, cardiovascular disease and cancer

open access: yesClinical and Translational Discovery, Volume 3, Issue 5, October 2023., 2023
1.Annexin A2 is a key repair protein that works with S100A10 and other S100 proteins to execute its membrane repair and extracellular roles. 2.Annexin A2 is a therapeutic target because the loss of annexin A2 function enhances cellular degeneration, which exacerbates muscular dystrophy and cardiovascular disease.
Victor G. Kayejo   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy